Airway eosinophilic inflammation indicates small airway dysfunction (SAD) in patients with mild stable or at risk for COPD – results from CAPTO-COPD
Mustafa Abdo(Heidelberg University), H Watz(LungenClinic Grosshansdorf), Frederik Trinkmann(Heidelberg University), Frauke Pedersen, Anne‐Marie Kirsten, Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel), Felix Herth(Heidelberg University)
Cited by 0
Related Papers
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452